Home | Division of Cancer Prevention

Making cancer prevention possible

An illustration displaying possible inherited risk carriers within a family.

Studies Focus on Testing Family Members of Cancer Gene Carriers

If your family member had cancer, would you want to know if you carried a gene mutation that increased your risk of the same cancer? This question is at the heart of three novel research projects underway to determine how best to connect with the family members of women with ovarian cancer so they can decide whether to get genetic testing and counseling about their own risk of cancer.

NCI Division of Cancer Prevention: Precision Prevention, Biomarkers of Risk and Early Detection, Symptom Management

A Message from the Director: A Year of Making the Cancer Prevention Intention Clear

A year ago, I said that coming on board as the Division of Cancer Prevention Director in July 2020 was a “challenge,” adding that I had faith in science that the pandemic would be solved soon. Science has brought us a vaccine against SARS-CoV-2 and medicine to treat the disease, but we still aren’t all together in the workspace or many other places. We all look forward to that day.

MISSION STATEMENT

The Division of Cancer Prevention furthers the mission of the National Cancer Institute by leading, supporting, and promoting rigorous, innovative research and training to prevent cancer and its consequences to improve the health of all people.

Commemoration of the 50th Anniversary of the National Cancer Act - Champions and Changemakers

Kenneth Kinzler, Ph.D.
Detecting Tumor DNA in Blood

Kenneth Kinzler, Ph.D., is a molecular geneticist widely recognized for his role in helping to identify genetic mutations that initiate development of most colorectal cancers. As a co-director, with Bert Vogelstein, M.D., of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center, the duo...

Bert Vogelstein, M.D.
Understanding Genes and Pathways in a Developing Cancer

In the late 1980s, Bert Vogelstein, M.D., became the first scientist to unravel the molecular basis of one of the most common genetic mutations in all cancers: errors in the p53 gene. That discovery led to the creation of a specific model for human carcinogenesis, fondly known as...

Avrum Spira, M.D., M.Sc.
Probing Lung Cancer’s Field of Injury

Lung cancer, the leading cause of cancer deaths worldwide, is often detected in late stages when treatments may not be as effective. Early in his career, Avrum Spira, M.D., M.Sc., dealt with this firsthand when treating a patient who came to Boston Medical Center with worsening shortness of...

David S. Alberts, M.D.
Translational Cancer Prevention

Trained in oncology and clinical pharmacology, David Alberts, M.D., became an early advocate of cancer prevention research, long before he took over as director of the University of Arizona’s Comprehensive Cancer Center in 2005. Although he retired in 2013, Dr. Alberts now serves as the...

Latest News

Read All News

Meetings and Events

Review All Our Meetings and Events

Accelerating the Development of Pediatric Physical Activity Interventions

Date(s):

Monday, December 6, 2021 - 2:00pm - 3:30pm EST

Location: Virtual via WebEx

Strengths, Weaknesses, and Reproducibility in Nutritional Randomized Clinical Trials (RTC) and Epidemiological Studies

Date(s):

Friday, December 10, 2021 - 11:00am - 1:00pm EST

Location: Virtual via WebEx

PCDC EDRN-APaCC Joint (Virtual) Meeting Registration Now Open

Date(s):

Monday, December 13, 2021 - 10:30am - 5:30pm EST

Location: Virtual via WebEx

Charting the Course of Liquid Biopsy in Precision Prevention and Treatment

Date(s):

Wednesday, December 15, 2021 - 11:00am - 3:45pm EST
Thursday, December 16, 2021 - 11:00am - 3:45pm EST

Location: Virtual via WebEx

Studies Focus on Testing Family Members of Cancer Gene Carriers

A Message from the Director: A Year of Making the Cancer Prevention Intention Clear

MISSION STATEMENT

Commemoration of the 50th Anniversary of the National Cancer Act - Champions and Changemakers

Latest News

Nutrition Frontiers - Fall 2021

Job Opening for DCP Deputy Director and Chief Technology Officer

CP-CTNet Newsletter

Study Seeks to Unravel the Complexity of Rare Blood Disorders Known as Myelodysplastic Syndromes (MDS)

Meetings and Events

Accelerating the Development of Pediatric Physical Activity Interventions

Strengths, Weaknesses, and Reproducibility in Nutritional Randomized Clinical Trials (RTC) and Epidemiological Studies

PCDC EDRN-APaCC Joint (Virtual) Meeting Registration Now Open

Charting the Course of Liquid Biopsy in Precision Prevention and Treatment

Twitter Feeds

@NCIprevention

@NCISymptomMgmt

@NCICastle

Policies

NCI's PDQ® Evidence-based Summaries

General Information

Search form

Studies Focus on Testing Family Members of Cancer Gene Carriers

A Message from the Director: A Year of Making the Cancer Prevention Intention Clear

MISSION STATEMENT

Commemoration of the 50th Anniversary of the National Cancer Act - Champions and Changemakers

Latest News

Nutrition Frontiers - Fall 2021

Job Opening for DCP Deputy Director and Chief Technology Officer

CP-CTNet Newsletter

Study Seeks to Unravel the Complexity of Rare Blood Disorders Known as Myelodysplastic Syndromes (MDS)

Meetings and Events

Accelerating the Development of Pediatric Physical Activity Interventions

Strengths, Weaknesses, and Reproducibility in Nutritional Randomized Clinical Trials (RTC) and Epidemiological Studies

PCDC EDRN-APaCC Joint (Virtual) Meeting Registration Now Open

Charting the Course of Liquid Biopsy in Precision Prevention and Treatment

Twitter Feeds

@NCIprevention

@NCISymptomMgmt

@NCICastle

Follow us at: